X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - New Drug Applications - 05/Nov 01:11

Merus Receives FDA Extension of PDUFA for Zenocutuzumab

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies...

Articles similaires

Sorry! Image not available at this time

Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma

drugs.com - 12/Nov 18:11

CHICAGO and FORT WORTH, Texas, Nov. 12, 2024 (GLOBE NEWSWIRE) — Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the...

Sorry! Image not available at this time

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

drugs.com - 11/Nov 03:11

LOS ALTOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing...

Sorry! Image not available at this time

FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

drugs.com - 08/Nov 21:11

LONDON, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early-commercial stage biopharmaceutical company developing...

Sorry! Image not available at this time

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

mangaloremirror.com - 15/Nov 13:53

SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) —  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative...

Sorry! Image not available at this time

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

emiratesnewswire.ae - 07/Nov 13:25

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...

Sorry! Image not available at this time

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

africanewswire.za.com - 07/Nov 13:25

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...

Sorry! Image not available at this time

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

arabnewsnetwork.ps - 07/Nov 13:25

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...

Sorry! Image not available at this time

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

qatarnewswire.qa - 07/Nov 13:25

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...

Sorry! Image not available at this time

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

menafocus.qa - 07/Nov 13:25

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...

Sorry! Image not available at this time

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

pressarabia.qa - 07/Nov 13:25

WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global...

Les derniers communiqués